Lincoln Pharmaceuticals Limited (BOM:531633)
India flag India · Delayed Price · Currency is INR
580.50
-1.40 (-0.24%)
At close: Jul 27, 2026

Lincoln Pharmaceuticals Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
878.94823.46933.05728.99693.55
Depreciation & Amortization
145127.98105.1990.5579.53
Other Amortization
-1.011.061.111.35
Loss (Gain) From Sale of Assets
-1.581.42.76-0.761.3
Loss (Gain) From Sale of Investments
-19.48-61.2-227.85-51.35-36.1
Provision & Write-off of Bad Debts
-8.751.496.5-1.785.27
Other Operating Activities
-26.11-55.69-27.36-60.42-7.61
Change in Accounts Receivable
58.25-47.79-260.86-202.12-31.19
Change in Inventory
-14.28-15.09-71.427.14-261.29
Change in Accounts Payable
-0.85125.08215.73-205.14145.93
Change in Other Net Operating Assets
52.4529.5-44.6466.39170.6
Operating Cash Flow
1,064930.16632.17392.62761.32
Operating Cash Flow Growth
14.34%47.14%61.01%-48.43%9.91%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-254.28-190.29-394.76-142.59-455.25
Sale of Property, Plant & Equipment
15.191.220.97.060.79
Sale (Purchase) of Intangibles
-6.12-2.15-1.37-0.23-
Investment in Securities
-328.74-286.83-248.05106.14-125.3
Other Investing Activities
-3.8425.38305.48-140.95-81.26
Investing Cash Flow
-984.04-789.47-573.41-366.43-780.8

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
44.22684.2200193.5720
Total Debt Issued
44.22684.2200193.5720
Short-Term Debt Repaid
--694.17-209.02-195.02-
Long-Term Debt Repaid
-----5.2
Total Debt Repaid
--694.17-209.02-195.02-5.2
Net Debt Issued (Repaid)
44.22-9.97-9.02-1.4414.8
Common Dividends Paid
-36.05-36.05-30.05-30.05-30
Other Financing Activities
-6.57-17.99-12.74-13.52-10.36
Financing Cash Flow
1.59-64.02-51.8-45.01-25.56

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Cash Flow
81.1476.676.95-18.82-45.04

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
809.31739.86237.41250.03306.07
Free Cash Flow Growth
9.39%211.64%-5.05%-18.31%-49.43%
Free Cash Flow Margin
12.06%11.87%4.09%4.90%6.48%
Free Cash Flow Per Share
40.4036.9411.8512.4815.28
Levered Free Cash Flow
25.93448.04213.1444.5962.93
Unlevered Free Cash Flow
32.26454.26219.0554.8268.68

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
6.5717.9912.7413.5210.36
Cash Income Tax Paid
251.38263.07261.51296.1236.96
Change in Working Capital
95.5791.71-161.17-313.7424.05